A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

NCT07250802 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Zasocitinib
DRUG: Placebo
DRUG: Zasocitinib

Sponsor

Takeda